Tocilizumab for Relapsing Polychondritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01104480
Recruitment Status : Withdrawn (Tocilizumab was licenced in Canada for children, so the study was not necessary)
First Posted : April 15, 2010
Last Update Posted : May 13, 2014
Information provided by (Responsible Party):
Dr Maggie Larche, McMaster Children's Hospital

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : July 2010
  Estimated Study Completion Date : May 2012